Just imagine the exuberance if ORCL was still in the Nasdaq…Economic downgrade… 2 rate hikes this year… Buy Stocks you idiot!!With Utilities (but rates are notably higher) and Healthcare (Biotech bubble) leading the way…Here’s why…Average:5Your rating: None Average: 5 (2 votes)
Taken from:
Thank You Janet – Nasdaq Hits Record High
See which stocks are being affected by Social Media
[…]
Rxi Pharmaceuticals (NASDAQ:RXII)On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects:First the new patent is for a chemical modification that allows for […]
Biotech Stocks to BuyThis Biotech Stocks forecast is designed for investors and analysts who need predictions of the best performing stocks for the whole Biotechnology Industry (See Industry Package). It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to buy:Top 10 biotech stocks for the long position
Top 10 biotech stocks for the short position
Package Name: […]
Biotech stocks have been in a strong Upward trend for years. Both ETFs Nasdaq (IBB) and S&P (XBI) have been top performers. Recently the S&P (XBI) has rallied on to all time highs. The Nasdaq (IBB) has failed to take out all time highs. The Proshares Nasdaq Biotech ETF (2X) (BIB) is an excellent instrument. Now Direxionshares has recently introduced […]
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]
Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]
Tweet
Tweet
The Top Performing Stocks Of 2015by Bespoke InvestBelow is a list of the top performing stocks in the Russell 3,000 year-to-date. Of the 3,000 stocks in the index, 18 are up more than 100%. The best performer in the index is Retrophin (RTRX), which is up 161%. In recent years past, there have been at least a couple stocks up […]
Biotech Indices Can’t Break Through Triple Top
IBB at $365, XBI at $239
Red and green day
Biotech stocks were mixed today with the major indices holding the flat line. However with all of the clinical data coming out of ASCO (American Society for Clinical Oncology) 2015 in Chicago, IL many “immuno-oncology” stocks were movers.
First look at Rayno Biopharmaceutical Portfolio stocks:
Our big mover […]
For one top technician, there are only two names that matter to the market right now: Apple and biotech.”The correlation between Apple and biotech is outstanding,” technical analyst Carter Worth said Friday on CNBC’s “Options Action.” In what he’s dubbing the “king and queen” of the market, Worth said, “The way the two act, you’d think nothing else in the […]
For the 4th day in a row, China opened with a dip last night, but this time it was different. A half-hearted BTFD-effort was met with major selling pressure. Between real-estate developer Kaisa’s failed bailout and yet another entity defaulting (Zhuhai Zhongfu stock plummetted) it appears the 8% rip of the last few days in the Shenzhen Composite was just […]
